vs
Protalix BioTherapeutics, Inc.（PLX）与Velo3D, Inc.（VELO）财务数据对比。点击上方公司名可切换其他公司
Velo3D, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.0倍（$9.4M vs $9.1M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -231.9%，领先171.6%），Velo3D, Inc.同比增速更快（-25.2% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-8.3M），过去两年Velo3D, Inc.的营收复合增速更高（-1.8% vs -6.7%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
Velo3D是全球领先的金属3D打印解决方案提供商，主营工业级金属3D打印机、配套专用加工软件及高性能金属材料，主要服务航空航天、国防、能源、半导体等高端制造领域，可生产传统工艺难以实现的复杂高精度金属零部件。
PLX vs VELO — 直观对比
营收规模更大
VELO
是对方的1.0倍
$9.1M
营收增速更快
VELO
高出24.7%
-49.9%
净利率更高
PLX
高出171.6%
-231.9%
自由现金流更多
PLX
多$10.0M
$-8.3M
两年增速更快
VELO
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $9.4M |
| 净利润 | $-5.5M | $-21.9M |
| 毛利率 | 49.4% | -73.6% |
| 营业利润率 | -51.1% | -231.0% |
| 净利率 | -60.3% | -231.9% |
| 营收同比 | -49.9% | -25.2% |
| 净利润同比 | -184.8% | -2.9% |
| 每股收益（稀释后） | $-0.06 | $-0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXVELO
| Q4 25 | $9.1M | $9.4M | ||
| Q3 25 | $17.9M | $13.6M | ||
| Q2 25 | $15.7M | $13.6M | ||
| Q1 25 | $10.1M | $9.3M | ||
| Q4 24 | $18.2M | $12.6M | ||
| Q3 24 | $18.0M | $8.2M | ||
| Q2 24 | $13.5M | $10.3M | ||
| Q1 24 | — | $9.8M |
净利润PLXVELO
| Q4 25 | $-5.5M | $-21.9M | ||
| Q3 25 | $2.4M | $-11.2M | ||
| Q2 25 | $164.0K | $-13.3M | ||
| Q1 25 | $-3.6M | $-25.0M | ||
| Q4 24 | $6.5M | $-21.3M | ||
| Q3 24 | $3.2M | $-21.9M | ||
| Q2 24 | $-2.2M | $935.0K | ||
| Q1 24 | — | $-27.5M |
毛利率PLXVELO
| Q4 25 | 49.4% | -73.6% | ||
| Q3 25 | 53.4% | 3.2% | ||
| Q2 25 | 62.5% | -11.7% | ||
| Q1 25 | 19.1% | 7.5% | ||
| Q4 24 | 78.7% | -3.5% | ||
| Q3 24 | 53.4% | 49.4% | ||
| Q2 24 | 29.8% | -28.0% | ||
| Q1 24 | — | -28.8% |
营业利润率PLXVELO
| Q4 25 | -51.1% | -231.0% | ||
| Q3 25 | 11.9% | -73.3% | ||
| Q2 25 | 7.5% | -85.4% | ||
| Q1 25 | -41.0% | -123.6% | ||
| Q4 24 | 39.6% | -167.0% | ||
| Q3 24 | 22.2% | -213.8% | ||
| Q2 24 | -18.0% | -187.7% | ||
| Q1 24 | — | -211.1% |
净利率PLXVELO
| Q4 25 | -60.3% | -231.9% | ||
| Q3 25 | 13.2% | -82.0% | ||
| Q2 25 | 1.0% | -97.7% | ||
| Q1 25 | -35.8% | -268.4% | ||
| Q4 24 | 35.6% | -168.5% | ||
| Q3 24 | 18.0% | -265.3% | ||
| Q2 24 | -16.4% | 9.0% | ||
| Q1 24 | — | -281.2% |
每股收益（稀释后）PLXVELO
| Q4 25 | $-0.06 | $-0.87 | ||
| Q3 25 | $0.03 | $-0.65 | ||
| Q2 25 | $0.00 | $-0.94 | ||
| Q1 25 | $-0.05 | $-1.87 | ||
| Q4 24 | $0.10 | $7.06 | ||
| Q3 24 | $0.03 | $-35.52 | ||
| Q2 24 | $-0.03 | $1.65 | ||
| Q1 24 | — | $-55.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $39.0M |
| 总债务越低越好 | — | $31.0M |
| 股东权益账面价值 | $48.2M | $38.2M |
| 总资产 | $82.3M | $105.3M |
| 负债/权益比越低杠杆越低 | — | 0.81× |
8季度趋势，按日历期对齐
现金及短期投资PLXVELO
| Q4 25 | $14.7M | $39.0M | ||
| Q3 25 | $13.6M | $11.8M | ||
| Q2 25 | $17.9M | $854.0K | ||
| Q1 25 | $19.5M | $3.9M | ||
| Q4 24 | $19.8M | $1.2M | ||
| Q3 24 | $27.4M | $1.6M | ||
| Q2 24 | $23.4M | $3.2M | ||
| Q1 24 | — | $10.9M |
总债务PLXVELO
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $32.3M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $44.0M |
股东权益PLXVELO
| Q4 25 | $48.2M | $38.2M | ||
| Q3 25 | $52.9M | $29.9M | ||
| Q2 25 | $49.9M | $21.4M | ||
| Q1 25 | $45.2M | $32.8M | ||
| Q4 24 | $43.2M | $39.7M | ||
| Q3 24 | $32.4M | $34.4M | ||
| Q2 24 | $28.6M | $52.1M | ||
| Q1 24 | — | $45.5M |
总资产PLXVELO
| Q4 25 | $82.3M | $105.3M | ||
| Q3 25 | $82.3M | $93.7M | ||
| Q2 25 | $78.5M | $78.4M | ||
| Q1 25 | $73.9M | $91.3M | ||
| Q4 24 | $73.4M | $89.2M | ||
| Q3 24 | $61.6M | $110.8M | ||
| Q2 24 | $91.5M | $116.7M | ||
| Q1 24 | — | $136.1M |
负债/权益比PLXVELO
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.97× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-7.7M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-8.3M |
| 自由现金流率自由现金流/营收 | 17.8% | -88.3% |
| 资本支出强度资本支出/营收 | 4.4% | 6.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | — |
8季度趋势，按日历期对齐
经营现金流PLXVELO
| Q4 25 | $2.0M | $-7.7M | ||
| Q3 25 | $-3.7M | $-6.0M | ||
| Q2 25 | $-5.2M | $-1.2M | ||
| Q1 25 | $-5.1M | $-12.3M | ||
| Q4 24 | $4.0M | $-2.2M | ||
| Q3 24 | $4.1M | $-2.0M | ||
| Q2 24 | $-3.6M | $-8.0M | ||
| Q1 24 | — | $-20.5M |
自由现金流PLXVELO
| Q4 25 | $1.6M | $-8.3M | ||
| Q3 25 | $-4.2M | $-6.3M | ||
| Q2 25 | $-5.7M | $-3.0M | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | $-2.2M | ||
| Q3 24 | $4.0M | $-2.0M | ||
| Q2 24 | $-3.8M | $-8.0M | ||
| Q1 24 | — | $-20.5M |
自由现金流率PLXVELO
| Q4 25 | 17.8% | -88.3% | ||
| Q3 25 | -23.7% | -46.5% | ||
| Q2 25 | -36.2% | -22.2% | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | -17.7% | ||
| Q3 24 | 22.4% | -24.2% | ||
| Q2 24 | -28.1% | -77.1% | ||
| Q1 24 | — | -209.8% |
资本支出强度PLXVELO
| Q4 25 | 4.4% | 6.4% | ||
| Q3 25 | 2.8% | 2.3% | ||
| Q2 25 | 2.8% | 13.3% | ||
| Q1 25 | 3.0% | 0.0% | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 0.5% | 0.2% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率PLXVELO
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | -8.52× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
VELO
暂无分部数据
